title: Breast-conserving surgery in breast cancer.
abstract: The breast cancer treatment is based nowadays on new surgical options: breast-conserving surgery, which applies at least for the first and second stage cancer, with radical intention. We have been practicing breast-conserving surgery for the last 16 years and we have performed 303 breast conserving operations from a total of 673. We recorded 12 local recurrences (3,96%) and 2 deaths due to cancer progression. Our protocol includes removal of the primary tumor with enough surrounding tissue to ensure negative margins of the resectable specimen, associated with axillary lymph-node dissection and postoperative breast irradiation. Our oncologist indicated chemotherapy on different postoperative conditions: tumor size, axillary lymph node involvement, patient's age, etc. The purpose of this paper is to emphasize our modest experience, nevertheless to draw the attention on important results, obtained by long-term monitoring of the patients who underwent breast-conserving surgery, in a two prospective protocols, and demonstrate the importance and applicability of breast conserving therapy. The conclusion of this study is that breast-conserving surgery followed by breast irradiation is reliable, as the results are similar with radical mastectomies; the main objective is to obtain a good cosmetic result, which depends on tumor size / breast size.
authors.affiliation: Department of General Surgery, C F Clinical Hospital, Craiova, Romania. doctortts@yahoo.com
authors.forename: T S
authors.initials: TS
authors.lastname: Tenea Cojan
authors.forename: C D
authors.initials: CD
authors.lastname: Vidrighin
authors.forename: M
authors.initials: M
authors.lastname: Ciobanu
authors.forename: I
authors.initials: I
authors.lastname: Paun
authors.forename: M
authors.initials: M
authors.lastname: Teodorescu
authors.forename: G
authors.initials: G
authors.lastname: Mogos
authors.forename: M
authors.initials: M
authors.lastname: Tenovici
authors.forename: M
authors.initials: M
authors.lastname: Florescu
authors.forename: D
authors.initials: D
authors.lastname: Mogos
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D002277:Carcinoma / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008197:Lymph Node Excision; D015412:Mastectomy, Segmental / Q000379:methods* / Q000706:statistics & numerical data*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012383:Romania / Q000453:epidemiology; D012424:Rural Population / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014505:Urban Population / Q000706:statistics & numerical data